{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T15:52:41Z","timestamp":1793721161896,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T00:00:00Z","timestamp":1729814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100013254","name":"National College Students Innovation and Entrepreneurship Training Program","doi-asserted-by":"publisher","award":["202210598040"],"award-info":[{"award-number":["202210598040"]}],"id":[{"id":"10.13039\/501100013254","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant","award":["2023GXNSFAA026338"],"award-info":[{"award-number":["2023GXNSFAA026338"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803564"],"award-info":[{"award-number":["81803564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13060-5","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:02:14Z","timestamp":1729828934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-omics analysis identifies PTTG1 as a prognostic biomarker associated with immunotherapy and chemotherapy resistance"],"prefix":"10.1186","volume":"24","author":[{"given":"Handong","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlin","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,25]]},"reference":[{"key":"13060_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1098\/rstb.2004.1615","volume":"360","author":"M Yanagida","year":"2005","unstructured":"Yanagida M. Basic mechanism of eukaryotic chromosome segregation. Philos Trans R Soc Lond B Biol Sci. 2005;360:609\u201321. https:\/\/doi.org\/10.1098\/rstb.2004.1615.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"13060_CR2","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1083\/jcb.200506119","volume":"172","author":"KG Wirth","year":"2006","unstructured":"Wirth KG, Wutz G, Kudo NR, Desdouets C, Zetterberg A, Taghybeeglu S, Seznec J, Ducos GM, Ricci R, Firnberg N, et al. Separase: a universal trigger for sister chromatid disjunction but not chromosome cycle progression. J Cell Biol. 2006;172:847\u201360. https:\/\/doi.org\/10.1083\/jcb.200506119.","journal-title":"J Cell Biol"},{"key":"13060_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ncb1707","volume":"10","author":"P Marangos","year":"2008","unstructured":"Marangos P, Carroll J. Securin regulates entry into M-phase by modulating the stability of cyclin B. Nat Cell Biol. 2008;10:445\u201351. https:\/\/doi.org\/10.1038\/ncb1707.","journal-title":"Nat Cell Biol"},{"key":"13060_CR4","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/ng997","volume":"32","author":"JA Bernal","year":"2002","unstructured":"Bernal JA, Luna R, Espina A, Lazaro I, Ramos-Morales F, Romero F, Arias C, Silva A, Tortolero M, Pintor-Toro JA. Human securin interacts with p53 and modulates p53-mediated transcriptional activity and apoptosis. Nat Genet. 2002;32:306\u201311. https:\/\/doi.org\/10.1038\/ng997.","journal-title":"Nat Genet"},{"key":"13060_CR5","doi-asserted-by":"publisher","first-page":"4302","DOI":"10.1091\/mbc.E10-10-0838","volume":"22","author":"MA Moreno-Mateos","year":"2011","unstructured":"Moreno-Mateos MA, Espina AG, Torres B, del Gamez MM, Romero-Franco A, Rios RM, Pintor-Toro JA. PTTG1\/securin modulates microtubule nucleation and cell migration. Mol Biol Cell. 2011;22:4302\u201311. https:\/\/doi.org\/10.1091\/mbc.E10-10-0838.","journal-title":"Mol Biol Cell"},{"key":"13060_CR6","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1158\/0008-5472.CAN-22-3561","volume":"83","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Li L, Sha F, Lei Y, Tian X, Chen L, Chen Y, Liu H, Guo Y. PTTG1 reprograms Asparagine metabolism to promote Hepatocellular Carcinoma Progression. Cancer Res. 2023;83:2372\u201386. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3561.","journal-title":"Cancer Res"},{"key":"13060_CR7","doi-asserted-by":"publisher","unstructured":"Bai L, Li LH, Liang J, Li EX. (2022). Prognostic Significance of PTTG1 and Its Methylation in Lung Adenocarcinoma. J Oncol 2022, 3507436. https:\/\/doi.org\/10.1155\/2022\/3507436","DOI":"10.1155\/2022\/3507436"},{"key":"13060_CR8","doi-asserted-by":"publisher","first-page":"119594","DOI":"10.1016\/j.lfs.2021.119594","volume":"277","author":"Z Chen","year":"2021","unstructured":"Chen Z, Cao K, Hou Y, Lu F, Li L, Wang L, Xia Y, Zhang L, Chen H, Li R, et al. PTTG1 knockdown enhances radiation-induced antitumour immunity in lung adenocarcinoma. Life Sci. 2021;277:119594. https:\/\/doi.org\/10.1016\/j.lfs.2021.119594.","journal-title":"Life Sci"},{"key":"13060_CR9","doi-asserted-by":"publisher","first-page":"656697","DOI":"10.3389\/fphar.2021.656697","volume":"12","author":"H Hong","year":"2021","unstructured":"Hong H, Jin Z, Qian T, Xu X, Zhu X, Fei Q, Yang J, Sui C, Xu M. Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma via Down-regulating the STAT3-Modulated PTTG1 pathway. Front Pharmacol. 2021;12:656697. https:\/\/doi.org\/10.3389\/fphar.2021.656697.","journal-title":"Front Pharmacol"},{"key":"13060_CR10","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for Comprehensive Analysis of Tumor-infiltrating Immune cells. Cancer Res. 2017;77:e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"key":"13060_CR11","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45:W98\u2013102. https:\/\/doi.org\/10.1093\/nar\/gkx247.","journal-title":"Nucleic Acids Res"},{"key":"13060_CR12","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhlen","year":"2015","unstructured":"Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson A, Kampf C, Sjostedt E, Asplund A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347:1260419. https:\/\/doi.org\/10.1126\/science.1260419.","journal-title":"Science"},{"key":"13060_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362\u201374. https:\/\/doi.org\/10.1111\/bph.16257.","journal-title":"Br J Pharmacol"},{"key":"13060_CR14","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.CAN-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn I, Kundra R, Mastrogiacomo B, Tran TN, Sikina L, Mazor T, Li X, Ochoa A, Zhao G, Lai B, et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal. Cancer Res. 2023;83:3861\u20137. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0816.","journal-title":"Cancer Res"},{"key":"13060_CR15","doi-asserted-by":"publisher","unstructured":"Liu CJ, Hu FF, Xie GY, Miao YR, Li XW, Zeng Y, Guo AY. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24. https:\/\/doi.org\/10.1093\/bib\/bbac558.","DOI":"10.1093\/bib\/bbac558"},{"key":"13060_CR16","doi-asserted-by":"publisher","first-page":"D1300","DOI":"10.1093\/nar\/gkac966","volume":"51","author":"H Zhou","year":"2023","unstructured":"Zhou H, Arapoglou T, Li X, Li Z, Zheng X, Moore J, Asok A, Kumar S, Blue EE, Buyske S, et al. FAVOR: functional annotation of variants online resource and annotator for variation across the human genome. Nucleic Acids Res. 2023;51:D1300\u201311. https:\/\/doi.org\/10.1093\/nar\/gkac966.","journal-title":"Nucleic Acids Res"},{"key":"13060_CR17","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498\u2013504. https:\/\/doi.org\/10.1101\/gr.1239303.","journal-title":"Genome Res"},{"key":"13060_CR18","doi-asserted-by":"publisher","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10. https:\/\/doi.org\/10.1038\/s41467-019-09234-6.","DOI":"10.1038\/s41467-019-09234-6"},{"key":"13060_CR19","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, Li Z, Traugh N, Bu X, Li B, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24:1550\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0136-1.","journal-title":"Nat Med"},{"key":"13060_CR20","doi-asserted-by":"publisher","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","volume":"49","author":"D Sun","year":"2021","unstructured":"Sun D, Wang J, Han Y, Dong X, Ge J, Zheng R, Shi X, Wang B, Li Z, Ren P, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49:D1420\u201330. https:\/\/doi.org\/10.1093\/nar\/gkaa1020.","journal-title":"Nucleic Acids Res"},{"key":"13060_CR21","doi-asserted-by":"publisher","first-page":"D1083","DOI":"10.1093\/nar\/gkaa968","volume":"49","author":"A Luna","year":"2021","unstructured":"Luna A, Elloumi F, Varma S, Wang Y, Rajapakse VN, Aladjem MI, Robert J, Sander C, Pommier Y, Reinhold WC. CellMiner Cross-database (CellMinerCDB) version 1.2: exploration of patient-derived cancer cell line pharmacogenomics. Nucleic Acids Res. 2021;49:D1083\u201393. https:\/\/doi.org\/10.1093\/nar\/gkaa968.","journal-title":"Nucleic Acids Res"},{"key":"13060_CR22","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling T, Irwin JJ. ZINC 15\u2013Ligand Discovery for everyone. J Chem Inf Model. 2015;55:2324\u201337. https:\/\/doi.org\/10.1021\/acs.jcim.5b00559.","journal-title":"J Chem Inf Model"},{"key":"13060_CR23","doi-asserted-by":"publisher","unstructured":"Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y. Tumor biomarkers for diagnosis, prognosis and targeted therapy. Signal Transduct Target Ther. 2024;9. https:\/\/doi.org\/10.1038\/s41392-024-01823-2.","DOI":"10.1038\/s41392-024-01823-2"},{"key":"13060_CR24","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/s41568-024-00705-7","volume":"24","author":"AM Holder","year":"2024","unstructured":"Holder AM, Dedeilia A, Sierra-Davidson K, Cohen S, Liu D, Parikh A, Boland GM. Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours. Nat Rev Cancer. 2024;24:498\u2013512. https:\/\/doi.org\/10.1038\/s41568-024-00705-7.","journal-title":"Nat Rev Cancer"},{"key":"13060_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.31083\/j.fbl2902087","volume":"29","author":"L Wang","year":"2024","unstructured":"Wang L, Liu X. Multi-omics Analysis of the oncogenic value of pituitary tumor-transforming gene 1 (PTTG1) in human cancers. Front Biosci (Landmark Ed). 2024;29:87. https:\/\/doi.org\/10.31083\/j.fbl2902087.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"13060_CR26","doi-asserted-by":"publisher","first-page":"e1730","DOI":"10.1002\/ctm2.1730","volume":"14","author":"H Zhang","year":"2024","unstructured":"Zhang H, Chang Z, Wang C, Yuan Z, Liu Y, Wang Y, Zhang W, Zhong Y, Wang M, Zou C, et al. SKA3\/PTTG1\/c-MYC signal loop drives the progression of colorectal cancer. Clin Transl Med. 2024;14:e1730. https:\/\/doi.org\/10.1002\/ctm2.1730.","journal-title":"Clin Transl Med"},{"key":"13060_CR27","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1038\/s41388-023-02767-7","volume":"42","author":"X Zhang","year":"2023","unstructured":"Zhang X, Wu N, Huang H, Li S, Liu S, Zhang R, Huang Y, Lyu H, Xiao S, Ali DW, et al. Phosphorylated PTTG1 switches its subcellular distribution and promotes \u03b2-catenin stabilization and subsequent transcription activity. Oncogene. 2023;42:2439\u201355. https:\/\/doi.org\/10.1038\/s41388-023-02767-7.","journal-title":"Oncogene"},{"key":"13060_CR28","doi-asserted-by":"publisher","first-page":"e13201","DOI":"10.1016\/j.heliyon.2023.e13201","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang X, Ji H, Huang Y, Zhu B, Xing Q. Elevated PTTG1 predicts poor prognosis in kidney renal clear cell carcinoma and correlates with immunity. Heliyon. 2023;9:e13201. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e13201.","journal-title":"Heliyon"},{"key":"13060_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015;15:486\u201399. https:\/\/doi.org\/10.1038\/nri3862.","journal-title":"Nat Rev Immunol"},{"key":"13060_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","volume":"36","author":"KE Pauken","year":"2015","unstructured":"Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol. 2015;36:265\u201376. https:\/\/doi.org\/10.1016\/j.it.2015.02.008.","journal-title":"Trends Immunol"},{"key":"13060_CR31","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","volume":"19","author":"A Chow","year":"2022","unstructured":"Chow A, Perica K, Klebanoff CA, Wolchok JD. Clinical implications of T cell exhaustion for cancer immunotherapy. Nat Rev Clin Oncol. 2022;19:775\u201390. https:\/\/doi.org\/10.1038\/s41571-022-00689-z.","journal-title":"Nat Rev Clin Oncol"},{"key":"13060_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03271-5","author":"AS Bhagwat","year":"2024","unstructured":"Bhagwat AS, Torres L, Shestova O, Shestov M, Mellors PW, Fisher HR, Farooki SN, Frost BF, Loken MR, Gaymon AL, et al. Cytokine-mediated CAR T therapy resistance in AML. Nat Med. 2024. https:\/\/doi.org\/10.1038\/s41591-024-03271-5.","journal-title":"Nat Med"},{"key":"13060_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12964-024-01834-0","volume":"22","author":"J Liu","year":"2024","unstructured":"Liu J, Wu M, Yang Y, Mei X, Wang L, Wang J, Wang Z, He S, Liu H, Jiang H, et al. BTN3A1 expressed in cervical cancer cells promotes V\u03b39V\u03b42 T cells exhaustion through upregulating transcription factors NR4A2\/3 downstream of TCR signaling. Cell Commun Signal. 2024;22:459. https:\/\/doi.org\/10.1186\/s12964-024-01834-0.","journal-title":"Cell Commun Signal"},{"key":"13060_CR34","doi-asserted-by":"publisher","unstructured":"Terranova-Barberio M, Pawlowska N, Dhawan M, Moasser M, Chien AJ, Melisko ME, Rugo H, Rahimi R, Deal T, Daud A, et al. Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer. Nat Commun. 2020;11. https:\/\/doi.org\/10.1038\/s41467-020-17414-y.","DOI":"10.1038\/s41467-020-17414-y"},{"key":"13060_CR35","doi-asserted-by":"crossref","unstructured":"Ficial M, Jegede OA, Sant\u2019Angelo M, Hou Y, Flaifel A, Pignon JC, Braun DA, Wind-Rotolo M, Sticco-Ivins MA, Catalano PJ, et al. Expression of T-Cell exhaustion molecules and human endogenous retroviruses as predictive biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma. Clin Cancer Res. 2021;27:1371\u201380. https:\/\/doi.org\/10.1158\/1078\u20130432. CCR-20-3084","DOI":"10.1158\/1078-0432.CCR-20-3084"},{"key":"13060_CR36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood.2023020528","volume":"143","author":"J Bae","year":"2024","unstructured":"Bae J, Kitayama S, Herbert Z, Daheron L, Kurata K, Keskin DB, Livak K, Li S, Tarannum M, Romee R, et al. Differentiation of BCMA-specific induced pluripotent stem cells into rejuvenated CD8\u03b1\u03b2\u2009+\u2009T cells targeting multiple myeloma. Blood. 2024;143:895\u2013911. https:\/\/doi.org\/10.1182\/blood.2023020528.","journal-title":"Blood"},{"key":"13060_CR37","doi-asserted-by":"publisher","first-page":"684098","DOI":"10.3389\/fonc.2021.684098","volume":"11","author":"DR Principe","year":"2021","unstructured":"Principe DR, Chiec L, Mohindra NA, Munshi HG. Regulatory T-Cells as an emerging barrier to Immune Checkpoint Inhibition in Lung Cancer. Front Oncol. 2021;11:684098. https:\/\/doi.org\/10.3389\/fonc.2021.684098.","journal-title":"Front Oncol"},{"key":"13060_CR38","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai S, Togashi Y, Kamada T, Sugiyama E, Nishinakamura H, Takeuchi Y, Vitaly K, Itahashi K, Maeda Y, Matsui S, et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat Immunol. 2020;21:1346\u201358. https:\/\/doi.org\/10.1038\/s41590-020-0769-3.","journal-title":"Nat Immunol"},{"key":"13060_CR39","doi-asserted-by":"publisher","unstructured":"Yang C, Guo Y, Wu Z, Huang J, Xiang B. Comprehensive analysis of cuproptosis-related genes in prognosis and Immune Infiltration of Hepatocellular Carcinoma based on bulk and single-cell RNA sequencing data. Cancers (Basel). 2022;14. https:\/\/doi.org\/10.3390\/cancers14225713.","DOI":"10.3390\/cancers14225713"},{"key":"13060_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-018-0142-8","volume":"16","author":"JS O\u2019Donnell","year":"2019","unstructured":"O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol. 2019;16:151\u201367. https:\/\/doi.org\/10.1038\/s41571-018-0142-8.","journal-title":"Nat Rev Clin Oncol"},{"key":"13060_CR41","doi-asserted-by":"publisher","first-page":"e28278","DOI":"10.1016\/j.heliyon.2024.e28278","volume":"10","author":"D Xu","year":"2024","unstructured":"Xu D, Chen X, Wu M, Bi J, Xue H, Chen H. Identification of cellular senescence-associated genes as new biomarkers for predicting the prognosis and immunotherapy response of non-small cell lung cancer and construction of a prognostic model. Heliyon. 2024;10:e28278. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28278.","journal-title":"Heliyon"},{"key":"13060_CR42","doi-asserted-by":"publisher","unstructured":"Long L, Gao J, Zhang R. PTTG1 enhances Oncolytic Adenovirus 5 entry into pancreatic adenocarcinoma cells by increasing CXADR expression. Viruses. 2023;15. https:\/\/doi.org\/10.3390\/v15051153.","DOI":"10.3390\/v15051153"},{"key":"13060_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2344","author":"HC Toh","year":"2024","unstructured":"Toh HC, Yang MH, Wang HM, Hsieh CY, Chitapanarux I, Ho KF, Hong RL, Ang MK, Colevas AD, Sirachainan E, et al. Gemcitabine, carboplatin, and Epstein Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase 3 trial. Ann Oncol. 2024. https:\/\/doi.org\/10.1016\/j.annonc.2024.08.2344.","journal-title":"Ann Oncol"},{"key":"13060_CR44","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1038\/s41467-024-51386-7","volume":"15","author":"D Liu","year":"2024","unstructured":"Liu D, Yan J, Ma F, Wang J, Yan S, He W. Reinvigoration of cytotoxic T lymphocytes in microsatellite instability-high colon adenocarcinoma through lysosomal degradation of PD-L1. Nat Commun. 2024;15:6922. https:\/\/doi.org\/10.1038\/s41467-024-51386-7.","journal-title":"Nat Commun"},{"key":"13060_CR45","doi-asserted-by":"publisher","first-page":"683419","DOI":"10.3389\/fonc.2021.683419","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Tong Z, Zhang W, Zhang W, Buzdin A, Mu X, Yan Q, Zhao X, Chang HH, Duhon M, et al. FDA-Approved and emerging next generation predictive biomarkers for Immune checkpoint inhibitors in Cancer patients. Front Oncol. 2021;11:683419. https:\/\/doi.org\/10.3389\/fonc.2021.683419.","journal-title":"Front Oncol"},{"key":"13060_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/er.2006-0042","volume":"28","author":"G Vlotides","year":"2007","unstructured":"Vlotides G, Eigler T, Melmed S. Pituitary tumor-transforming gene: physiology and implications for tumorigenesis. Endocr Rev. 2007;28:165\u201386. https:\/\/doi.org\/10.1210\/er.2006-0042.","journal-title":"Endocr Rev"},{"key":"13060_CR47","doi-asserted-by":"publisher","first-page":"18050","DOI":"10.1002\/cam4.6411","volume":"12","author":"S Sahni","year":"2023","unstructured":"Sahni S, Nahm C, Ahadi MS, Sioson L, Byeon S, Chou A, Maloney S, Moon E, Pavlakis N, Gill AJ, et al. Gene expression profiling of pancreatic ductal adenocarcinomas in response to neoadjuvant chemotherapy. Cancer Med. 2023;12:18050\u201361. https:\/\/doi.org\/10.1002\/cam4.6411.","journal-title":"Cancer Med"},{"key":"13060_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cts.12413","volume":"9","author":"I Nakachi","year":"2016","unstructured":"Nakachi I, Helfrich BA, Spillman MA, Mickler EA, Olson CJ, Rice JL, Coldren CD, Heasley LE, Geraci MW, Stearman RS. PTTG1 levels are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell lines. Clin Transl Sci. 2016;9:293\u2013301. https:\/\/doi.org\/10.1111\/cts.12413.","journal-title":"Clin Transl Sci"},{"key":"13060_CR49","doi-asserted-by":"crossref","unstructured":"Castilla C, Flores ML, Medina R, Perez-Valderrama B, Romero F, Tortolero M, Japon MA, Saez C. Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1. Mol Cancer Ther. 2014;13:2372\u201383. https:\/\/doi.org\/10.1158\/1535\u20137163.MCT-13-0405","DOI":"10.1158\/1535-7163.MCT-13-0405"},{"key":"13060_CR50","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.celrep.2017.04.077","volume":"19","author":"MP Dalvi","year":"2017","unstructured":"Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, et al. Taxane-platin-resistant lung cancers co-develop hypersensitivity to JumonjiC demethylase inhibitors. Cell Rep. 2017;19:1669\u201384. https:\/\/doi.org\/10.1016\/j.celrep.2017.04.077.","journal-title":"Cell Rep"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T04:03:39Z","timestamp":1729829019000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,25]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["13060"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13060-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4923978\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,25]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1315"}}